IP Library Granted Patent US 7,429,653
Granted Patent B2
US 7,429,653 · App. 11/126,797 · Granted Sep 30, 2008

Stabilized soluble glycoprotein trimers

Assignee: Dana-Farber Cancer Institute, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,429,653
App. No.
11/126,797
Granted
Sep 30, 2008
Kind
B2
Abstract

The present application is directed to stabilized HIV envelope glycoprotein trimers. The trimers are stabilized by introducing trimeric motifs, preferably the GCN4 coiled coil or the fibritin trimeric domain, at certain sites, for example in the gp41 ectodomain. These stabilized trimers or DNA molecules encoding such trimers can be used to generate an immunogenic reaction. The trimers can also be used in assays to screen for molecules that interact with them—and to identify molecules that interact with specific sites.

Claims (10)

1. An isolated molecule containing a nucleotide sequence encoding an HIV-1 or HIV-2 gp125 monomer, referred to as a gp120 monomer, wherein the gp120 monomers form a stable trimer, wherein the nucleic acid sequence encoding at least one of the gp120 monomers has been modified from the wildtype sequence to encode a modified gp120 monomer, wherein the modified gp120 monomer maintains the overall three-dimensional structure of the wildtype gp120, wherein a portion of one variable region has been deleted, and wherein a trimeric motif has been added carboxyl to the gp120 monomer's carboxyl terminus.

2. The isolated molecule of claim 1 encoding the modified gp120 monomer wherein the molecule encodes the complete external gp120 or gp125 glycoprotein.

3. The isolated molecule of claim 2 , wherein the external glycoprotein lacks portions of at least the V1 and V2 regions.

4. The isolated molecule of claim 3 , wherein the external glycoprotein is a modified HIV-1 gp120.

5. The isolated molecule of claim 1 , wherein the nucleotide sequence is a DNA sequence.

6. The isolated molecule of claim 1 , wherein the trimeric motif is the carboxyl terminus of each monomer.

7. The isolated molecule of claim 6 , wherein the trimeric motif is a coiled coil.

8. The isolated molecule of claim 6 , wherein the trimeric motif is a GCN4 trimeric motif or a fibritin trimeric motif.

9. The isolated molecule of claim 6 , wherein the trimeric motif is SEQ ID NO: 1.

10. The isolated molecule of claim 6 , wherein the trimeric motif is SEQ ID NO: 4.

Assignments (1)
CONFIRMATORY LICENSE Recorded Sep 20, 2016
From: DANA-FARBER CANCER INSTITUTE
To: NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR
Reel/Frame 040087/0418 →
Continuity (4)
Division 1010053400 · Mar 18, 2002
Continuation PCTUS002555700 · Sep 18, 2000
Provisional Application 6015467700 · Sep 17, 1999
Related Publication 20050220817A1 · Oct 6, 2005